Pliant Therapeutics Inc. (PLRX) Social Stream
PLIANT THERAPEUTICS INC (PLRX) Price Targets From Analysts
Use the tables below to see what analysts covering PLIANT THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 4 | $63 | $45 | $52.75 | $28.02 | 88.26% |
| 2021-11-24 | 5 | $63 | $38 | $49.8 | $28.02 | 77.73% |
| 2022-03-01 | 6 | $63 | $38 | $48.166 | $28.02 | 71.9% |
| 2022-05-11 | 5 | $63 | $38 | $46.5 | $28.02 | 65.95% |
| 2022-05-18 | 5 | $45 | $27 | $37.5 | $28.02 | 33.83% |
| 2022-06-01 | 6 | $45 | $27 | $35.6 | $28.02 | 27.05% |
| 2022-07-26 | 7 | $54 | $33 | $42 | $28.02 | 49.89% |
| 2022-08-11 | 7 | $54 | $33 | $43.833 | $28.02 | 56.43% |
| 2022-09-01 | 8 | $54 | $33 | $42.714 | $28.02 | 52.44% |
| 2022-11-18 | 8 | $53 | $33 | $42.142 | $28.02 | 50.4% |
| 2022-12-07 | 9 | $53 | $33 | $42.125 | $28.02 | 50.34% |
| 2023-01-22 | 10 | $53 | $33 | $41.111 | $28.02 | 46.72% |
| 2023-01-23 | 10 | $53 | $36 | $43.777 | $28.02 | 56.23% |
| 2023-02-08 | 11 | $55 | $40 | $46.7 | $28.02 | 66.67% |
| 2023-02-13 | 11 | $55 | $40 | $47.9 | $28.02 | 70.95% |
| 2023-03-10 | 11 | $55 | $40 | $48 | $28.02 | 71.31% |
| 2023-03-13 | 11 | $58 | $40 | $47.9 | $28.02 | 70.95% |
The Trend in the Analyst Price Target
Over the past 18 months, PLRX's average price target has gone down $3.43.
Over the past 44 weeks, PLRX's average upside potential has been 235.47%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-11 | 7 | 54 | 33 | 43.833 | 20.53 | 113.51% |
| 2022-11-18 | 8 | 53 | 33 | 42.142 | 20.09 | 109.77% |
| 2023-01-23 | 11 | 53 | 36 | 43.777 | 30.28 | 44.57% |
| 2023-02-08 | 11 | 55 | 40 | 47.900 | 31.74 | 50.91% |
| 2023-03-13 | 11 | 58 | 40 | 47.900 | 28.20 | 69.86% |
PLRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.18 | 9 | 2 | 0 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 90 days, PLRX's average broker recommendation rating worsened by 0.07.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of stocks in the small market cap category, PLIANT THERAPEUTICS INC's average analyst price target is higher than 2003.36% of them.
- In the context of stocks in the small market cap category, PLIANT THERAPEUTICS INC's number of analysts covering the stock is greater than 1895.15% of them.
- In terms of how PLIANT THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 681.59% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PLIANT THERAPEUTICS INC's variance in analysts' estimates is lower than -598.43% of them.
Stocks similar to PLIANT THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CALT, RNA, and GBIO.
View All Top Stocks by Price Target
Make investment decisions regarding PLRX using the data that counts. Try POWR Ratings for free.